$376 Million is the total value of Wildcat Capital Management, LLC's 21 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 73.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KITE | Buy | KITE PHARMA INC | $249,848,000 | +35.0% | 2,410,034 | +2.2% | 66.42% | +13.3% |
| CSGP | Sell | COSTAR GROUP INC | $47,889,000 | +21.2% | 181,672 | -4.7% | 12.73% | +1.8% |
| NK | Sell | NANTKWEST INC | $25,742,000 | +61.7% | 3,391,539 | -24.4% | 6.84% | +35.7% |
| LPLA | Buy | LPL FINL HLDGS INC | $8,801,000 | +6.9% | 208,401 | +0.8% | 2.34% | -10.2% |
| EMB | ISHARES TRjp mor em mk etf | $7,943,000 | +0.6% | 70,000 | 0.0% | 2.11% | -15.6% | |
| UNIT | Buy | UNITI GROUP INC | $6,612,000 | +56.9% | 263,000 | +61.3% | 1.76% | +31.7% |
| New | MIMEDX GROUP INCcall | $5,853,000 | – | 391,000 | +100.0% | 1.56% | – | |
| SRNE | SORRENTO THERAPEUTICS INC | $5,599,000 | -49.4% | 2,799,790 | 0.0% | 1.49% | -57.5% | |
| PLYA | New | PLAYA HOTELS & RESORTS NV | $3,585,000 | – | 300,000 | +100.0% | 0.95% | – |
| SBR | New | SABINE ROYALTY TRunit ben int | $2,859,000 | – | 74,505 | +100.0% | 0.76% | – |
| BABA | New | ALIBABA GROUP HLDG LTDsponsored ads | $2,828,000 | – | 20,068 | +100.0% | 0.75% | – |
| FXY | CURRENCYSHS JAPANESE YEN TRjapanese yen | $2,672,000 | -1.1% | 31,245 | 0.0% | 0.71% | -17.1% | |
| URGN | New | UROGEN PHARMA LTD | $2,439,000 | – | 135,000 | +100.0% | 0.65% | – |
| NH | NANTHEALTH INC | $1,010,000 | -14.7% | 238,828 | 0.0% | 0.27% | -28.3% | |
| New | CURRENCYSHARES EURO TRput | $997,000 | – | 9,023 | +100.0% | 0.26% | – | |
| New | POWERSHS DB MULTI SECT COMMcall | $728,000 | – | 29,400 | +100.0% | 0.19% | – | |
| EDIT | EDITAS MEDICINE INC | $693,000 | -24.8% | 41,324 | 0.0% | 0.18% | -37.0% | |
| ADVM | ADVERUM BIOTECHNOLOGIES INC | $38,000 | -7.3% | 15,000 | 0.0% | 0.01% | -23.1% | |
| Exit | TESLA INCput | $0 | – | -1,100 | -100.0% | -0.10% | – | |
| Exit | ISHARES TRcall | $0 | – | -9,560 | -100.0% | -0.89% | – | |
| MDXG | Exit | MIMEDX GROUP INC | $0 | – | -1,080,365 | -100.0% | -3.26% | – |
| Exit | POWERSHS DB US DOLLAR INDEXput | $0 | – | -985,100 | -100.0% | -8.10% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| COSTAR GROUP INC | 32 | Q3 2022 | 48.3% |
| UROGEN PHARMA LTD | 26 | Q3 2023 | 17.3% |
| META PLATFORMS INC | 26 | Q3 2023 | 9.9% |
| ALLOGENE THERAPEUTICS INC | 18 | Q3 2023 | 22.4% |
| GOOSEHEAD INSURANCE INC -A | 18 | Q3 2023 | 15.4% |
| SABINE RTY TRUST | 18 | Q3 2021 | 11.3% |
| LPL FINL HLDGS INC | 18 | Q1 2019 | 12.7% |
| PLAYA HOTELS & RESORTS NV | 18 | Q3 2021 | 3.4% |
| NANTKWEST INC | 17 | Q3 2019 | 22.0% |
| SORRENTO THERAPEUTICS INC | 17 | Q2 2019 | 7.0% |
View Wildcat Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Skillz Inc. | January 05, 2023 | 19,596,988 | 5.6% |
| UroGen Pharma Ltd. | February 14, 2022 | 533,139 | 2.4% |
| Skillz Inc. | March 08, 2021 | 21,832,022 | 7.5% |
| NantKwest, Inc. | February 13, 2018 | 808,974 | 1.0% |
| Sorrento Therapeutics, Inc. | February 13, 2018 | 1,738,232 | 2.2% |
View Wildcat Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-04-08 |
| SC 13G | 2024-04-08 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-09 |
| PX14A6G | 2023-11-03 |
| 13F-HR | 2023-08-11 |
| 13F-HR/A | 2023-08-10 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-07 |
| SC 13D/A | 2023-01-05 |
View Wildcat Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.